Delivery Order SPE2DB22D3501-SPE2DB25FUB46
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $33,681.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 31, 2024. This award is part of AmerisourceBergen's larger Indefinite Delivery...
This federal contract award, valued at $6,553.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566758197 ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting.
The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,441.86 firm fixed price delivery order is for the supply of ondansetron odt 4 mg tablets, a medication used for nausea and vomiting. The award has an ultimate completion date of October 31, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $3,464.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566374364 - Ondansetron ODT 4 mg Tablets, a generic medication used to treat nausea and vomiting.
The contract has a firm fixed price and an ultimate completion date of November 12, 2024. Amerisourcebergen is the prime contractor, and the...
This federal contract award, valued at $4,736.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting, with a performance period extending to November 13, 2024. The contract is structured as a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open...
This federal contract award, valued at $5,178.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,566,307,493 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a completion date of November 4, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,357.08 delivery order contract is for the provision of 4566688936 - Ondansetron ODT 4 MG Tablet 30S, a medication used to prevent nausea and vomiting. The contract has a firm fixed price pricing type and a completion date of December 12, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,101.36 delivery order contract is for the supply of 500 tablets of 4 mg Ondansetron HCl, a medication commonly used to treat nausea and vomiting. The contract has an ultimate completion date of April 5, 2023 and utilizes a firm fixed price pricing arrangement. This delivery order is part of a larger Indefinite...
This federal contract award, valued at $1,320.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,436 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a completion date of November 15, 2024 and is structured as a firm fixed-price Delivery Order, with no set-aside designation. Amerisourcebergen...
This federal contract award, valued at $6,234.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4566050454 - Ondansetron ODT 4 mg Tablets (30 count), a pharmaceutical product used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for...